Print

Cisbio International Adds To HTRF Portfolio With Introduction Of Kinase And Ubiquitin Toolboxes; Company Expands Line Of High-throughput Screening Solutions 
10/19/2005 5:10:41 PM

Cisbio international, an established developer of HTRF(R) technology and services used in assay development and drug screening, announced the availability of two novel assay toolboxes for use in high throughput screening applications. The new kinase and ubiquitin toolboxes will cover a broad range of kinase and polyubiquitination-related targets.
//-->